| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group | 
| FLULAVAL TETRA 15 micrograms per 0.5 milliliter suspension for injection ID Biomedical Corporation of Quebec (real clinical drug) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 2 | 
| Pediatric vaccine product containing only diptheria standard dose + pertussis standard dose + tetanus + hepatitis B + Haemophilus influenzae type b antigens (medicinal product) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 1 | 
| TETRAMUNE suspension for injection Wyeth-Ayerst Canada Inc. (real clinical drug) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 3 | 
| DTaP-Hib ACTacel SP | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 3 | 
| Xanaflu 15 micrograms per 0.5 milliliter suspension for injection Drug Safety, Abbott Laboratories, Limited (real clinical drug) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 3 | 
| Pediatric vaccine product containing only diphtheria standard dose + tetanus + acellular pertussis standard dose + hepatitis b + inactivated human poliovirus antigens (medicinal product) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 2 | 
| Pediatric vaccine product containing only diphtheria standard dose + tetanus + acellular pertussis standard dose + hepatitis b + inactivated human poliovirus antigens (medicinal product) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 1 | 
| Xanaflu 15 micrograms per 0.5 milliliter suspension for injection Drug Safety, Abbott Laboratories, Limited (real clinical drug) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 2 | 
| TETRAMUNE suspension for injection Wyeth-Ayerst Canada Inc. (real clinical drug) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 1 | 
| Inf INFLUVAC BGP | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 3 | 
| Inf INFLUVAC BGP | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 2 | 
| HA EPAXAL BB | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 1 | 
| Inf AGRIFLU SEQ | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 3 | 
| Inf AGRIFLU SEQ | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 1 | 
| Inf AGRIFLU SEQ | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 2 | 
| Inf INFLUVAC BGP | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 1 | 
| DTaP-Hib ACTacel SP | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 1 | 
| Xanaflu 15 micrograms per 0.5 milliliter suspension for injection Drug Safety, Abbott Laboratories, Limited (real clinical drug) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 1 | 
| DTwP-HB Tritanrix GSK | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 1 | 
| DTwP-HB Tritanrix GSK | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 2 | 
| Inf AFLURIA TETRA SEQ | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 3 | 
| Inf AFLURIA TETRA SEQ | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 1 | 
| Inf AFLURIA TETRA SEQ | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 2 | 
| Inf AFLURIA TETRA SEQ | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 4 | 
| INFLUVAC TETRA 15 micrograms per 0.5 milliliter suspension for injection BGP Pharma ULC (real clinical drug) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 4 | 
| INFLUVAC TETRA 15 micrograms per 0.5 milliliter suspension for injection BGP Pharma ULC (real clinical drug) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 2 | 
| INFLUVAC TETRA 15 micrograms per 0.5 milliliter suspension for injection BGP Pharma ULC (real clinical drug) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 1 | 
| INFLUVAC TETRA 15 micrograms per 0.5 milliliter suspension for injection BGP Pharma ULC (real clinical drug) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 3 | 
| AVAXIM 160 units per 0.5 milliliter suspension for injection Sanofi Pasteur Limited (real clinical drug) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 1 | 
| INFANRIX hexa suspension for injection GlaxoSmithKline Inc. (real clinical drug) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 8 | 
| INFANRIX hexa suspension for injection GlaxoSmithKline Inc. (real clinical drug) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 1 | 
| Vaxigrip 15 micrograms per 0.5 milliliter suspension for injection Sanofi Pasteur SA (real clinical drug) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 1 | 
| Vaxigrip 15 micrograms per 0.5 milliliter suspension for injection Sanofi Pasteur SA (real clinical drug) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 2 | 
| Vaxigrip 15 micrograms per 0.5 milliliter suspension for injection Sanofi Pasteur SA (real clinical drug) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 3 | 
| Pediatric vaccine product containing whole cell pertussis standard dose antigen (medicinal product) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 1 | 
| Pediatric vaccine product containing diphtheria standard dose + pertussis standard dose + tetanus + human poliovirus antigens (medicinal product) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 2 | 
| Pediatric vaccine product containing diphtheria standard dose + pertussis standard dose + tetanus + human poliovirus antigens (medicinal product) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 1 | 
| DTwP-HB diptheria + tetanus + whole cell pertussis + hepatitis B pediatric unspecified | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 2 | 
| HAHB Hepatitis A + B regular strength unspecified | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 1 | 
| DTwP-HB diptheria + tetanus + whole cell pertussis + hepatitis B pediatric unspecified | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 1 | 
| INFLUSPLIT TETRA 15 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Biologicals (real clinical drug) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 4 | 
| INFLUSPLIT TETRA 15 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Biologicals (real clinical drug) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 3 | 
| INFLUSPLIT TETRA 15 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Biologicals (real clinical drug) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 1 | 
| INFLUSPLIT TETRA 15 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Biologicals (real clinical drug) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 2 | 
| FLUVIRAL 15 micrograms per 0.5 milliliter suspension for injection ID Biomedical Corporation of Quebec (real clinical drug) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 3 | 
| FLUVIRAL 15 micrograms per 0.5 milliliter suspension for injection ID Biomedical Corporation of Quebec (real clinical drug) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 1 | 
| FLUVIRAL 15 micrograms per 0.5 milliliter suspension for injection ID Biomedical Corporation of Quebec (real clinical drug) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 2 | 
| Adult vaccine product containing only Hepatitis B virus regular strength antigen (medicinal product) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 1 | 
| DPT-Hib suspension for injection Aventis Pasteur Limited (real clinical drug) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 1 | 
| DPT-Hib suspension for injection Aventis Pasteur Limited (real clinical drug) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 2 | 
| DTaP-Hib diphtheria + tetanus + acellular pertussis + Haemophilus influenzae type b pediatric unspecified | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 2 | 
| DTaP-Hib diphtheria + tetanus + acellular pertussis + Haemophilus influenzae type b pediatric unspecified | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 1 | 
| RECOMBIVAX HB 10 micrograms per milliliter suspension for injection Merck Canada Inc. (real clinical drug) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 1 | 
| INFANRIX-IPV suspension for injection GlaxoSmithKline Inc. (real clinical drug) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 5 | 
| INFANRIX-IPV suspension for injection GlaxoSmithKline Inc. (real clinical drug) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 1 | 
| Pediatric vaccine product containing only diphtheria standard dose + pertussis standard dose + tetanus + inactivated poliovirus antigens (medicinal product) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 2 | 
| Pediatric vaccine product containing acellular pertussis antigen in standard dose (medicinal product) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 1 | 
| Pediatric vaccine product containing only diphtheria standard dose + pertussis standard dose + tetanus + inactivated poliovirus antigens (medicinal product) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 1 | 
| Epaxal Berna 500 radioimmunoassay units per 0.5 milliliter suspension for injection Swiss Serum and Vaccine Institute Berne (real clinical drug) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 1 | 
| FLUZONE Quadrivalent 15 micrograms per 0.5 milliliter suspension for injection Sanofi Pasteur Limited (real clinical drug) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 2 | 
| FLUZONE Quadrivalent 15 micrograms per 0.5 milliliter suspension for injection Sanofi Pasteur Limited (real clinical drug) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 1 | 
| FLUZONE Quadrivalent 15 micrograms per 0.5 milliliter suspension for injection Sanofi Pasteur Limited (real clinical drug) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 4 | 
| FLUZONE Quadrivalent 15 micrograms per 0.5 milliliter suspension for injection Sanofi Pasteur Limited (real clinical drug) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 3 | 
| DPTPH DPT-Polio-Hib AP | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 2 | 
| DPTPH DPT-Polio-Hib AP | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 1 | 
| Adjuvanted vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus standard dose each non-live antigen in parenteral dose form (medicinal product form) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 2 | 
| Adjuvanted vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus standard dose each non-live antigen in parenteral dose form (medicinal product form) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 3 | 
| Adjuvanted vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus standard dose each non-live antigen in parenteral dose form (medicinal product form) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 1 | 
| VAQTA 50 units per milliliter suspension for injection Merck Canada Inc. (real clinical drug) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 1 | 
| DCaT-VPI-Hib PENTACEL SP | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 2 | 
| DCaT-VPI-Hib PENTACEL SP | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 1 | 
| INFLUVAC 15 micrograms per 0.5 milliliter suspension for injection Drug Safety, Abbott Laboratories, Limited (real clinical drug) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 2 | 
| INFLUVAC 15 micrograms per 0.5 milliliter suspension for injection Drug Safety, Abbott Laboratories, Limited (real clinical drug) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 1 | 
| Pediatric vaccine product containing only diphtheria standard dose + tetanus antigens (medicinal product) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 1 | 
| INFLUVAC 15 micrograms per 0.5 milliliter suspension for injection Drug Safety, Abbott Laboratories, Limited (real clinical drug) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 3 | 
| DTaP-IPV KINRIX GSK | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 1 | 
| Influenza A (H1N1) 2009 Pandemic Monovalent Vaccine (Without Adjuvant) 15 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 1 | 
| DTaP-IPV KINRIX GSK | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 5 | 
| Inf FLUAD SEQ | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 2 | 
| Inf FLUAD SEQ | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 3 | 
| Inf FLUAD SEQ | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 1 | 
| INFANRIX-IPV/Hib suspension for injection GlaxoSmithKline Inc. (real clinical drug) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 1 | 
| Intanza 15 micrograms per 0.1 milliliter suspension for injection Sanofi Pasteur SA (real clinical drug) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 1 | 
| INFANRIX-IPV/Hib suspension for injection GlaxoSmithKline Inc. (real clinical drug) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 2 | 
| Intanza 15 micrograms per 0.1 milliliter suspension for injection Sanofi Pasteur SA (real clinical drug) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 3 | 
| Intanza 15 micrograms per 0.1 milliliter suspension for injection Sanofi Pasteur SA (real clinical drug) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 2 | 
| Pediatric vaccine product containing only diphtheria standard dose + pertussis standard dose + tetanus + human poliovirus + Haemophilus influenza type b antigens (medicinal product) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 1 | 
| Pediatric vaccine product containing only diphtheria standard dose + pertussis standard dose + tetanus + human poliovirus + Haemophilus influenza type b antigens (medicinal product) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 2 | 
| Unadjuvanted vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus Victoria and Yamagata lineage standard dose each non-live antigen in parenteral dose form (medicinal product form) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 1 | 
| Unadjuvanted vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus Victoria and Yamagata lineage standard dose each non-live antigen in parenteral dose form (medicinal product form) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 3 | 
| Unadjuvanted vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus Victoria and Yamagata lineage standard dose each non-live antigen in parenteral dose form (medicinal product form) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 4 | 
| Unadjuvanted vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus Victoria and Yamagata lineage standard dose each non-live antigen in parenteral dose form (medicinal product form) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 2 | 
| Tripacel Hybrid suspension for injection Sanofi Pasteur Limited (real clinical drug) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 1 | 
| Engerix B 20 micrograms per milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 1 | 
| Tripacel Hybrid suspension for injection Sanofi Pasteur Limited (real clinical drug) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 2 | 
| PEDIACEL suspension for injection Sanofi Pasteur Limited (real clinical drug) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 1 | 
| Pediatric vaccine product containing only diphtheria standard dose + tetanus + acellular pertussis standard dose + hepatitis b + inactivated human poliovirus + Haemophilus influenzae type b antigens (medicinal product) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 6 | 
| Pediatric vaccine product containing only diphtheria standard dose + tetanus + acellular pertussis standard dose + inactivated human poliovirus + Haemophilus influenzae type b antigens (medicinal product) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 2 | 
| Pediatric vaccine product containing diphtheria standard dose + pertussis standard dose + tetanus antigens (medicinal product) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 1 | 
| Pediatric vaccine product containing diphtheria standard dose + pertussis standard dose + tetanus antigens (medicinal product) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 2 | 
| PEDIACEL suspension for injection Sanofi Pasteur Limited (real clinical drug) | Has ingredient qualitative strength | True | Standard dose (qualifier value) | Inferred relationship | Some | 2 |